APCVP 2025

Message from the President

As the President of the Korean Society of Cardiovascular Pharmacotherapy (KSCVP), it is my great pleasure to warmly welcome you to the 2025 Asia Pacific Cardiovascular Pharmacotherapy (APCVP 2025) and KSCVP 2025 conference.

With the support of international societies and experts, KSCVP has made significant strides in advancing cardiovascular pharmacotherapy. Our conferences have played an essential role in promoting evidence-based clinical practices, contributing to the prevention and treatment of cardiovascular diseases, and enhancing public health.

Our mission is to foster interdisciplinary collaboration among researchers, pharmacologists, biomedical scientists, and other professionals. Through the exchange of knowledge, education, and cooperation, we aim to drive future advancements in medicine and public health.

We are delighted to invite you to participate in APCVP 2025, which will take place on December 5th (Fri) and 6th (Sat), 2025, at the Grand Walkerhill Hotel in Seoul, South Korea. This conference will provide a significant platform for distinguished experts from around the world to share their knowledge and discuss the future of cardiovascular pharmacotherapy.

We are confident that your participation will greatly contribute to the success of the conference, and we sincerely appreciate your support.

We look forward to welcoming you to this prestigious event.